| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC1482 |
| Trial ID | NCT02159495 |
| Disease | Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm | Acute Biphenotypic Leukemia |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD123 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm |
| Year | 2014 |
| Country | United States |
| Company sponsor | City of Hope Medical Center |
| Other ID(s) | 13272|NCI-2014-01147|13272 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||
|
|||||||||||